Back

News & Publications

 

  • April 24th Meeting of Ophthalmic Devices Advisory Panel Postponed
    Saratoga, CA - April 22, 2008 - VisionCare Ophthalmic Technologies, Inc... today announced that the review of the investigational Implantable Miniature Telescope (IMT™ by Dr. Isaac Lipshitz) by the FDA Ophthalmic Devices Advisory Panel, originally scheduled for April 24, has been postponed.
    Read More

  • VisionCare Ophthalmic Technologies Announces Presentations on Implantable Telescope for End-Stage Macular Degeneration at ARVO Annual Meeting
    Saratoga, CA – May 1, 2007 - VisionCare Ophthalmic Technologies, Inc... announced today two presentations on its platform technology are scheduled at the upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting May 6 - 10, 2007, in Fort Lauderdale, Florida.
    Read More

  • VisionCare Ophthalmic Technologies Announces Presentations at the American Society of Cataract and Refractive Surgery Annual Meeting
    Saratoga, CA - April 25, 2007 - VisionCare Ophthalmic Technologies, Inc... announced today two presentations on its platform technology are scheduled at the upcoming annual symposium of the American Society of Cataract and Refractive Surgery (ASCRS) April 27 – May 2, 2007, in San Diego.
    Read More

  • Results of Implantable Telescope Trial Published in Ophthalmology Report on Vision and Quality of Life in Patients with End-Stage Age-Related Macular Degeneration
    Saratoga, CA – November 1, 2006 – VisionCare Ophthalmic Technologies, Inc... announced today that results from the Phase II/III clinical trial of the investigational Implantable Miniature Telescope (IMTTM by Dr. Isaac Lipshitz) have been published in the November issue of Ophthalmology, the official journal of the American Academy of Ophthalmology.
    Read More

  • VisionCare Ophthalmic Technologies Announces Presentations at the Annual Meeting of the American Society of Cataract and Refractive Surgery
    Saratoga, CA – March 17, 2006 - VisionCare Ophthalmic Technologies, Inc... announced today three presentations on its platform technology are scheduled at the upcoming annual symposium of the American Society of Cataract and Refractive Surgery (ASCRS) March 18 - 21, 2006, in San Francisco.
    Read More

  • VisionCare Pivotal Study Shows Improved Vision and Quality of Life Outcomes in Patients with Age-Related Macular Degeneration
    Saratoga, CA - October 19, 2005 - VisionCare Ophthalmic Technologies… today announced positive results from the Phase II/III clinical trial of the investigational Implantable Miniature Telescope (IMT™ by Dr. Isaac Lipshitz) in patients with the untreatable, end-stage form of AMD. One-year efficacy data from the prospective, multicenter trial showed patients had a mean improvement of over 3 lines in both distance and near best-corrected visual acuity…
    Read More

  • VisionCare Announces Presentations on Pivotal Trial Results at the American Academy of Ophthalmology Annual Meeting
    Saratoga, CA - October 11, 2005 - VisionCare Ophthalmic Technologies, Inc... announced today three presentations related to its pivotal trial of the Implantable Miniature Telescope (IMT™ by Dr. Isaac Lipshitz) are scheduled at the upcoming 109th Annual Meeting of the American Academy of Ophthalmology (AAO) in Chicago, IL from October 15 - 18, 2005 at McCormick Place convention center.
    Read More

  • VisionCare Appoints Joaquin Wolff Vice President of Global Marketing & Sales
    Saratoga, CA - June 9, 2005 - VisionCare Ophthalmic Technologies, Inc., a developer of advanced visual prosthetic devices for the treatment of age-related macular degeneration, today announced Joaquin V. Wolff has been appointed Vice President, Global Marketing and Sales. Mr. Wolff joins the company as it expands management capabilities and adds resources in preparation for commercialization of its products for treating end-stage macular degeneration in 2006.
    Read More

  • VisionCare Relocates and Expands Facility in Israel
    Saratoga, CA - June 8, 2005 - VisionCare Ophthalmic Technologies, Inc., developer of proprietary visual prosthetic devices for the treatment of macular degeneration and other central vision disorders, announced today it has completed a relocation of its subsidiary, VisionCare Ophthalmic Technologies Ltd., from Yehud to an expanded and upgraded facility in the Kiryat Ayre area of Petah Tikva.
    Read More

  • Michael J. Strauss, M.D., Joins VisionCare Board of Directors
    Saratoga, CA - June 6, 2005 - VisionCare Ophthalmic Technologies, Inc., a developer of advanced visual prosthetic devices for the treatment of age-related macular degeneration, today announced Michael J. Strauss, MD, MPH, has accepted an invitation to join VisionCare's Board of Directors.
    Read More

  • VisionCare Closes $20 Million Series D Financing
    Saratoga, CA – January 4, 2005 – VisionCare Ophthalmic Technologies... announced today it has closed a Series D financing totaling $20 million. The round was led by new investor Boston Scientific...
    Read More

  • VisionCare Announces Upcoming Macular Degeneration Clinical Trial Presentations at American Academy of Ophthalmology Meeting
    Saratoga, CA – October 19, 2004 – VisionCare Ophthalmic Technologies... announced today the following presentations are scheduled at the upcoming Joint Meeting of the American Academy of Ophthalmology...
    Read More

  • VisionCare Completes Enrollment of Macular Degeneration Phase II/III Pivotal Trial - Milestones Trigger Completion of Financing Round
    Saratoga, CA - October 31, 2003 - VisionCare Ophthalmic Technologies, Inc., focused on the development of proprietary visual prosthetic devices for the treatment of age-related macular degeneration (AMD) and other central vision disorders, announced today ...
    Read More

  • VisionCare Phase I Clinical Trial Results For Macular Degeneration Presented at ARVO
    Saratoga, CA - May 8, 2003 - Positive Phase I clinical trial results were reported today for the Implantable Miniature Telescope...
    Read More

  • VisionCare Begins Enrollment of Phase II/III Pivotal Trial for Macular Degeneration
    SARATOGA, CA - January 7, 2003 - VisionCare Ophthalmic Technologies, Inc. (VisionCare), announced today that it has begun enrolling patients in a multi-center Phase II/III...
    Read More

Media Materials

Click here for VisionCare images and materials for download

Peer-Reviewed Publications Related to US Clinical Trials

Colby KA, Chang DF, Stulting RD, Lane SS. Surgical placement of an optical prosthetic device for end-stage macular degeneration: The Implantable Miniature Telescope. Arch Ophthalmol. 2007;125:1118-21.

Hudson HL, Lane SS, Heier JS, Stulting RD, Singerman L, Lichter PR, Sternberg P, Chang DF. Implantable miniature telescope for the treatment of visual acuity loss due to end-stage age-related macular degeneration: one-year results. Ophthalmology. 2006;113:1987-2001.

Lane, SS, Kuppermann, BD. The Implantable Miniature Telescope for macular degeneration. Curr Opin Ophthalmol. 2006;17:94-8.

Chun DW, Heier JS, Raizman MB. Visual prosthetic device for bilateral end-stage macular degeneration. Expert Rev Med Devices. 2005;2:657-65.

Lane SS, Kuppermann BD, Fine IH, Hamill MB, Gordon JF, Chuck RS, Hoffman RS, Packer M, Koch DD. A prospective multicenter trial to evaluate the safety and effectiveness of the implantable miniature telescope. Am J Ophthalmol 2004;137:993-1001.